Kynam Capital Management, LP Uro Gen Pharma Ltd. Transaction History
Kynam Capital Management, LP
- $1.19 Billion
- Q1 2025
A detailed history of Kynam Capital Management, LP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Kynam Capital Management, LP holds 25,000 shares of URGN stock, worth $200,000. This represents 0.02% of its overall portfolio holdings.
Number of Shares
25,000Holding current value
$200,000% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding URGN
# of Institutions
139Shares Held
37.7MCall Options Held
91.4KPut Options Held
42.1K-
Rtw Investments, LP New York, NY3.83MShares$30.7 Million0.69% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.21MShares$25.7 Million0.74% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$18.4 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$17.6 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY2.15MShares$17.2 Million1.7% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $182M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...